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Summary
Traditionally, biomarkers of aging are classified as either pro-
longevity or antilongevity. Using longitudinal data sets from the
large-scale inbred mouse strain study at the Jackson Laboratory
Nathan Shock Center, we describe a protocol to identify two
kinds of biomarkers: those with prognostic implication for
lifespan and those with longitudinal evidence. Our protocol also
identifies biomarkers for which, at first sight, there is conflicting
evidence. Conflict resolution is possible by postulating a role
switch. In these cases, high biomarker values are, for example,
antilongevity in early life and pro-longevity in later life. Role-
switching biomarkers correspond to features that must, for
example, be minimized early, but maximized later, for optimal
longevity. The clear-cut pro-longevity biomarkers we found
reflect anti-inflammatory, anti-immunosenescent or anti-anaemic
mechanisms, whereas clear-cut antilongevity biomarkers reflect
inflammatory mechanisms. Many highly significant blood bio-
markers relate to immune system features, indicating a shift from
adaptive to innate processes, whereas most role-switching
biomarkers relate to blood serum features and whole-body
phenotypes. Our biomarker classification approach is applicable
to any combination of longitudinal studies with life expectancy
data, and it provides insights beyond a simplified scheme of
biomarkers for long or short lifespan.
Key words: aging; anti-aging; inflammation; lifespan; lon-
gevity; mice; senescence.
Introduction
Biomarkers of aging and animal studies
With the reduction in the burden of communicable disease and
improvements in nutrition, attention is turning to longevity and the
challenges that accompany increased longevity such as the desire for
healthy aging (Lozano et al., 2012). The identification of biomarkers,
which reveal information about the expected lifespan of an individual or
predict the status of fitness or health in the near or distant future, is an
important objective for aging research. As Baker & Sprott (1988) pointed
out, chronological age is not necessarily a good predictor of functional or
biological age, especially in later life. They defined a biomarker of aging
as a measurable biological feature of an organism that predicts
functional capacity at some later age better than chronological age. In
many cases, the standard functional capacity to be predicted is life
expectancy, measured in terms of lifespan. Biomarkers of aging then
provide prognostic evidence, and they are derived from correlations
between feature values at a certain age, or at a certain set of ages, and
life expectancy. Finding prognostic biomarkers of aging thus requires the
measurement of features in a (large) set of individuals exhibiting
different lifespans, and such data are scarce. Even longitudinal animal
data are few and far between and may not necessarily reflect the human
situation (Zahn et al., 2007).
In animal experiments, some measurements are destructive (i.e. the
animal must be sacrificed) or interventional (e.g. taking a sufficient
amount of blood may markedly influence the physiology of an animal),
so it is not always possible to determine the normal lifespan of the
animal for which the measurements were taken. In that case, studies
may be combined, with attendant problems of interpretation. If the
animals used are genetically closely related groups such as inbred
strains or breeds, then, for each strain, features can be measured at
certain ages, and, independently, life expectancy can be estimated. For
example, Urfer et al. (2011) enriched their breed-specific data on
cataracts in dogs by mean life expectancy and body size derived from
previous studies and reached the plausible conclusion that cataracts (as
well as body size) are prognostic of lifespan. The Nathan Shock Center
at the Jackson Laboratory has extensively characterized 32 commonly
used inbred strains for aging-related phenotypes and made the
primary data publicly available on the Mouse Phenome Database
(Sundberg et al., 2011; Yuan et al., 2011; Maddatu et al., 2012).
These data sets form the basis for the analyses presented here that
permit investigation of prognostic biomarkers of aging by combining
longitudinal studies of features (including blood count data, leucocyte
data, blood chemistry, body composition, etc.) and a separate study of
life expectancy, all done for about 30 strains. Standardization of
environment, assays and strains means that this represents the most
coherent and well-controlled lifelong study yet conducted in mam-
mals. The same individuals were tracked allowing true longitudinal
analysis, avoiding the interpretation problems of a cross-sectional
study.
The strains of mice include a specific set of short-lived strains that are
predisposed to specific diseases, triggering early death (Yuan et al.,
2009). Our study includes these strains, but we also reanalysed our data
excluding them. Moreover, we went further than (Yuan et al., 2009) by
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checking whether there are systematic differences between the longi-
tudinal trends of the features, comparing short-lived to longer-lived
mice. We find that there are few such differences. These observations
imply that in general, the features we investigated change at a roughly
similar speed in short-lived and longer-lived mice, and short-lived strains
die early due to reasons not related to these features, whereas longer-
lived strains age with slightly different speed towards the end of life. Our
observations justify (post hoc) choosing the same chronological ages for
all strains as time points for measurement and that measurements taken
at a specific chronological age can be analysed by aggregating over all
strains, no matter whether they are short-lived or longer-lived.
Approaches to biomarker classification
As described, biomarkers of aging are often defined by their quality of
being prognostic for life expectancy. As life expectancy data for many
individuals or strains are scarce, however, many studies establish
biomarkers of age instead of biomarkers of aging, and some even
confuse both concepts, (Gavrilov & Gavrilova, 2006). The biomarkers of
age concept is simply based on longitudinal or cross-sectional trends of
features as a function of time. According to Gavrilov & Gavrilova,
(2006), ‘the regular and progressive changes over time per se do not
constitute aging unless they produce some deleterious outcome
(failures)’. Using longitudinal evidence, biomarkers of age can therefore
be validated as biomarkers of aging if something is known about their
effects, using literature data to ascribe deleterious (negative) effects (or
correlates thereof) to biomarkers whose values go up, and beneficial
(positive) effects (or correlates thereof) to the ones whose values go
down.
Importantly, prognostic evidence and validated longitudinal evidence
for biomarkers of aging usually relate to an overlapping but not identical
time span in the life of the animals. Any prognosis involves a later time
point; therefore, prognostic biomarkers of aging tend to relate to early
effects that have consequences upon the later life of the animals. In turn,
longitudinal trends tend to involve late effects. Literature validation of
the biomarkers we found based on longitudinal observations reveals that
their upward or downward trend directly affects fitness at older ages.
Our identification of role-switching biomarkers will mostly depend on
the finding that a biomarker is classified as pro-aging (antilongevity)
based on prognostic evidence, but as anti-aging (pro-longevity) based on
validated longitudinal evidence. In these cases, the early effects that are
relevant for prognosis are opposite to the late effects, where a
longitudinal trend affects fitness. The situation is different in the clear-
cut cases, where prognostic evidence and validated longitudinal
evidence yield the same classification. Here, the direction of effects
does not change as a function of time. We will discuss the role of early
and late effects in more depth in the Discussion section.
In the analysis presented here, we search for biomarkers in the
Nathan Shock Center study data set. For each feature, we first identified
longitudinal trends by regression analysis. Such a regression is necessarily
the same as the estimation of the correlation of the feature with the age
of the animal. Longitudinal evidence without further validation yields
biomarkers of age, so we checked the literature for deleterious or
beneficial effects. Then, to check for prognostic evidence, we combined
the data with the life expectancy data set. More specifically, validated
longitudinal evidence and prognostic evidence allowed us to define a
classification rule to distinguish three major classes of biomarkers:
pro-longevity, pro-aging (antilongevity) and role-switching (antilongevity
at early time points, pro-longevity at later time points). We do not
necessarily suggest that the deleterious or beneficial effects we found in
the literature provide mechanisms directly affecting longevity or aging;
many of these should be considered correlative. Then again, as biological
processes form deeply entangled networks, many of the effects may
have both causative and correlative aspects.
Results
Clear-cut biomarkers of aging
We simultaneously performed regression to investigate the longitudinal
trends of all data set features and correlation as well as Cox analyses to
investigate their prognostic power for lifespan. From all data sets
(Data S1 Table 1), we selected features as putative biomarkers if they
had both validated longitudinal and prognostic evidence (see Fig. 1,
Experimental Procedures and Data S1 Table 3, for the rules employed).
Table 1 summarizes the final classification of these biomarkers based on
both their prognostic and longitudinal evidence. We note seven clear-
cut cases where both kinds of evidence are corroborative. These are
related to immune cells (B cells, lymphocytes; neutrophils), anaemia (red
blood cell count and linked measurements) and inflammation (magne-
sium, neutrophils), and their classification as pro-longevity or antilon-
gevity (neutrophils only) is clear cut. In these cases, there are potential
mechanisms already reported that can be invoked to explain the
observation. Specifically, the decrease in lymphocytes/B cells as protag-
onists of adaptive immunity and the increase in neutrophils suggest an
age-related shift of the immune system cell composition from adaptive
to innate, driven by cellular effects of proinflammatory cytokines and
chemokines. The anti-inflammatory effects of magnesium are described
in Barbagallo et al., (2009).
Role-switching biomarkers of aging
There are another five cases recorded in Table 1 where the two kinds of
evidence are in conflict and a role switch is suggested. These are related
to oxidative damage and anaemia (total serum iron and the CHr
measurement that is closely linked (Mast, 2002), with a weaker pattern)
or to metabolism and robustness (thyroxine, BMI, as well as heart rate
with a signal at 6 M; M = months). The apparently paradoxical
classification of the role-changing biomarkers as ‘early antilongevity,
late pro-longevity’ is biologically plausible and may be resolved. For
example, a switching role of serum iron may be explained from its
known role as a protagonist of oxidative damage through catalytic
generation of ROS (dominating its early effect) (Xu et al., 2010) and as a
correlate of anaemia (dominating its late effect). The switching role of
thyroxine (T4) follows already from its prognostic evidence alone. It is the
only feature with a switch in prognosis, predicting short lifespan at 6 M
and long lifespan at 12 M/18 M. Both cases may be explained by its
well-established promotion of anabolism and growth. Accordingly, we
suggest that its early ‘cellular hyperactivity’ confers metabolic and
physiological decompensation in later life, such as obesity and insulin
resistance. In contrast, its later activity contributes to a reasonable
amount of overweight that yields a state of robustness. This pattern is
reflected by body mass index and heart rate, with essentially the same
rationale. In particular, body mass index (BMI) is discussed extensively in
the literature. For a long time, a high body mass index defining
overweight status was considered disadvantageous for young and old
people alike. More recently, however, it was found that for older people,
overweight (but not obesity) has advantageous effects, possibly due to
the higher robustness it affords against disease (Auyeung & Lee, 2010;
Flegal et al., 2013).
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Detailed analysis and visualization of blood-based
biomarkers
Prognostic evidence in the blood count, leucocyte and blood serum
chemistry data is described by correlation charts in Figs 2–6. Moreover,
the order of features in these charts, from left to right, gives an indication
of their longitudinal trends, from negative (going down) to positive (going
up). The precise regression slopes for the longitudinal evidence are given
in Figs S7, S8 and S13 of Data S1 (Supporting information). Charts for all
other data sets are found in Data S1 (Supporting information) as well. For
all data sets, selection and classification of features can proceed in their
regression-based order, from left to right, checking the prognostic power
of the leftmost and the rightmost features (up to the red delimiter) with a
significant downtrend or uptrend, respectively. There are few gender-
specific differences in the regression-based ordering of the features. For
example, in the blood count data (Data S1 Fig. S7), there is only a notable
difference for the platelet count (nPlt) that is not prognostic.
Thebloodcountdataof femalemice (Fig. 2), and,morepronounced, of
male mice (Fig. 3) display the clear-cut pattern we already reported for
lymphocytes, red blood cells (and, related, haemoglobin and hematocrit)
aswell as for neutrophils (Table 1). Thus, features such as the redblood cell
count on the left,whose values godown longitudinally, tend tobe features
with positive correlations to life expectancy, and vice versa (for the
neutrophil count on the right). In other words, the clear-cut biomarkers
with both validated longitudinal and prognostic evidence are clearly
exposed. For the red blood count, prognostic evidence is muchweaker for
female than for male mice, possibly due to the stronger role of other
factors (e.g. hormonal changes) in female aging processes. On the other
hand, for the lymphocyte data (T cells and B cells, see the next paragraph),
prognostic evidence is weaker in male compared with female mice,
possibly due to ‘age-associated B cells’ (ABCs) that were recently found in
female mice only and implicated in autoimmunity (Rubtsov et al., 2011;
Kogut et al., 2012). ABCs are supposed to originate frommature nai
̈
ve B-
cell precursors, so wemay hypothesize that ABCs and ‘normal’ B cells are,
Fig. 1 Protocol of our biomarker classification scheme.
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to a certain extent, mutually exclusive. Then, in female mice, ABCs are
indicators of aging at the expense of ‘normal’ B cells, and the latter are
prognostic for long lifespan. The absolute number of lymphocytes
(nLYMPH) decreases slightly during aging and their percentage (pct-
LYMPH) strongly,while at the same time, thenumbers of cells of the innate
immune system increase (i.e. monocytes, basophilic, eosinophilic and, in
Table 1 Feature analysis results based on our biomarker classification protocol. Corroborative evidence exists if the prognostic and the longitudinal approaches to
biomarker classification agree. Conflicting evidence exists if the prognostic data (usually concerning early effects with consequences later in life) trigger a different
classification as compared to the validated longitudinal data (usually concerning late effects). Such conflicting evidence can be resolved by suggesting that the early effects of
high biomarker values are opposite to the late effects. In case of thyroxine, this role switch is already found in the prognostic data alone. Qualifiers are indicating that
observations are more pronounced for a specific gender (e.g. ‘pronounced in male’) or found (mostly) in specific age groups (6, 12, 18 or 24 M; M: months)
Feature Abbrevation
Evidence Known effect Classification
Prognostic Longitudinal Early Late Early Late
Corroborative evidence, clear-cut cases
B cells, lymphocytes B cells, LYMPH Long lifespan
(pronounced in female)
Down Anti-immunosenescent Pro-longevity
Red blood cells,
haemoglobin,
hematocrit
RBC, HGB, HCT Long lifespan
(pronounced in male)
Down Anti-anaemic Pro-longevity
Magnesium Mg Long lifespan
(pronounced at 12 M)
Down
(pronounced
in female)
Anti-inflammatory Pro-longevity
Neutrophils NEUT Short lifespan Up Pro-inflammatory Antilongevity
Conflicting evidence, resolvable by a role switch
Iron, also reticulocyte
corpuscular
haemoglobin
Fe, CHr Short lifespan
(pronounced at 12 M)
Down Damaging, in particular
by oxidative stress
Anti-anaemic Antilongevity Pro-longevity
Thyroxine T4 Short lifespan
(6 M, pronounced in male),
long lifespan (12 M/18 M,
pronounced in female)
Down Pro-anabolic Pro-robustness Antilongevity Pro-longevity
Body mass index,
heart rate
BMI, HR Short lifespan
(pronounced at 6 M)
Down Pro-anabolic Pro-robustness Antilongevity Pro-longevity
Fig. 2 Correlation analysis – female complete blood count data (data set: Peters4); irrelevant values (correlation < |0.2| or/and P-value < 0.05) are presented by open bars.
Two red delimiters allow distinguishing, from left to right, features with a significant downtrend, features with no longitudinal trend and features with a significant
uptrend. nBASO, basophil count; pctBASO, basophil percentage; CHr, reticulocyte corpuscular haemoglobin; nEOS, eosinophil count; pctEOS, eosinophil percentage; HGB,
haemoglobin; nLUC, large unstained cells count; pctLUC, large unstained cell percentage; nLYMPH, lymphocyte count; pctLYMPH, lymphocyte percentage; MCH, mean
RBC corpuscular haemoglobin content; MCHC, mean RBC haemoglobin concentration; MCV, mean RBC corpuscular volume; nMONO, monocyte count; pctMONO,
monocyte percentage; MPV, mean platelet volume; nNEUT, neutrophil count; pctNEUT, neutrophil percentage; pctHCT, hematocrit; nPlt, platelet count; nRBC,
red blood cell count; nRetic, reticulocyte count; pctRetic, reticulocyte percentage; nWBC, white blood cell count.
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particular, neutrophilic granulocytes). Thus, as a consequence of age, the
immune system composition shifts from the adaptive towards the innate.
This reflects the processes of ‘inflammaging’ (Franceschi et al., 2006) and
of ‘immunosenescence’ by involution of lymphocyte-producing thymic
tissue, that is, the degeneration of the organ where these cells differen-
tiate/mature (Domınguez-Gerpe & Rey-Mendez, 2003; Takahama, 2006;
Chinn et al., 2012). Consistent with this argument, a ‘T-cell activation’
module has been recently identified in humans, ‘marking age-associated
shifts in lymphocyte blood cell counts’ (Van den Akker et al., 2014). The
increase of neutrophil numbers was also reported by others (Kovacs et al.,
2009), as was an age-dependent increase in granulocyte/macrophage
progenitor cells (GMPs) (Rossi et al., 2005). In terms of percentages, a
Fig. 3 Correlation analysis – male complete blood count data (data set: Peters4). See Fig. 2 for further explanations.
Fig. 4 Correlation analysis – female leucocyte data (Data set: Petkova1); see Fig. 2 for details. The following abbreviations are used; for each abbreviation starting with ‘pct’
referring to a percentage, an analogous abbreviation with the prefix ‘n’ refers to the absolute count. pctBcells, B cells; pctCD4all, CD4 T-cells percentage; pctCD4effector,
CD4 T-cell subtype – effector cells percentage; pctCD4memcentral, CD4 T-cell subtype – central memory cells percentage; pctCD4memeffector, CD4 T-cell subtype –
effector memory cells percentage; pctCD4naive, CD4 T-cell subtype – naive cells percentage; pctCD8all, CD8 T-cells percentage; pctCD8effector, CD8 T-cell subtype –
effector cells percentage; pctCD8memcentral, CD8 T-cell subtype – central memory cells percentage; pctCD8memeffector, CD8 T-cell subtype – effector memory cells
percentage; pctCD8naive, CD8 T-cell subtype – naive cells percentage; pctEOS, eosinophil percentage; pctLYMPH, lymphocyte percentage; pctMONO, monocyte
percentage; pctNEUT, neutrophil percentage; pctNK, NK cells percentage; nWBC, white blood cell count.
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compositional shift in our blood count analyses may be triggered if only
one fraction changes in absolute numbers. However, both fractions
(lymphocytes and neutrophils) change in absolute numbers, in the same
direction as thepercentages. The samemeasurements can alsobe found in
the leucocyte data set, but with a stronger focus on neutrophil decline.
The leucocyte data set (Figs 4 and 5) closely matches the blood count
data set, for the features included in both. Additionally, a pronounced
decline is found in the leucocyte data set for many cells of the adaptive
immune system (CD4 and CD8 T cells, common suffix ‘all’) and, in
particular, for various effector cells (common suffix ‘effector’) and
natural killer (NK) cells as well as B cells. Some other leucocyte
percentages increase over time, such as memory cells (common suffix
‘mem’) and monocytes. The longitudinal increase but low prognostic
value of most memory cells may have a straightforward cause: these cells
simply accumulate as the immune system learns; they are just biomarkers
of age. The CD4 memory (effector) cells (nCD4memeffector) are an
Fig. 5 Correlation analysis – male leucocyte data (Data set: Petkova1). See Fig. 4 for further explanations.
Fig. 6 Correlation analysis – blood chemistry (data set: Yuan3); top: female, bottom: male; see Fig. 2 for details. ALB, plasma albumin; ALP, serum alkaline phosphatase;
ALT, plasma alanine aminotransferase; BUN, plasma blood urea nitrogen; Ca, serum calcium; Cl, serum chloride; CO2, dissolved-ionized carbon dioxide; Fe, serum iron; HDL,
plasma HDL cholesterol; K, serum potassium; LIP, plasma lipase; Mg, serum magnesium; Na, serum sodium; Phos, serum phosphorus; T4, serum thyroxine; TBIL, serum
bilirubin; TP, plasma total protein.
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exception, already noted by Miller et al. (1997). These cells are
prognostic for a short lifespan in female mice (12, 18 and 24 M data),
similarly to CD8 memory central cells (pctCD8memcentral) in male mice,
and while their number increases longitudinally as expected for
antilongevity biomarkers, we could not find a deleterious effect reported
in the literature for either. In fact, Miller et al., (1997) extensively
discussed three explanations of their prognostic value without reaching a
conclusion. Moreover, these authors point out a shift from na€ıve/virgin T
cells to memory cells. The loss of the former reflects immunosenescence.
An age-related increase in CD4 memory effector cells has also been
previously described (Saule et al., 2006). Finally, the percentage of all
CD8 cells (pctCD8all) is declining longitudinally, but it is prognostic for a
short lifespan, specifically in female mice (6, 12 and 18 M). As such, it is
a candidate for a role-switching biomarker (‘antilongevity early, pro-
longevity late’), but we could not find literature evidence for a beneficial
effect on lifespan that may be reduced as it declines.
In blood serum chemistry (Fig. 6), apart from magnesium, thyroxine
(T4) and iron as described above, we found some more interesting
features, which had, however, at most isolated prognostic value,
possibly because there is a strong influence of confounding factors,
some of them related to intake and excretion. Findings for these blood
chemistry features are described in Appendix S1 Results.
Re-analysis of data using Cox regression
To validate our results by a different method, Cox regression was used as
an alternative to lifespan correlation. Importantly, Cox regression analysis
confirmed our results presented in Table 1 (Data S4); concordance of
both types of analysis was already noted by Harper et al. (2004). In some
cases, we even observed a stronger signal, with higher consistency
between age groups and sexes: the percentages of lymphocytes and
neutrophils as well as CHr are more concordant in 6-month-old female
mice. This is also true for the red blood cell count (RBC) in females, which
is also more concordant with male, and in both sexes, the platelet count
(Plt) is more concordant with results obtained from longer-lived strains.
In males, the CHr signal is also stronger, but the signal for lymphocytes
and neutrophils is comparatively weaker. Natural killer cells and HDL
(high-density lipoprotein) emerge as markers in females, while K
(potassium) emerges as a marker in males. We also performed a
multivariate Cox analysis of the biomarkers listed in Table 1. As shown in
Data S5 (Supporting information), in 6-month-old mice, for example, the
most significant features are the number of B cells in females, and the
number of lymphocytes and the level of thyroxine (T4) in males.
Re-analysis of data based on longer-lived strains only
The results of our re-analysis, excluding the short-lived strains, are
documented in Data S2 (Supporting information). There are few
relevant features gained or lost in the longer-lived strains, as follows.
For the blood count data, the platelet count (Plt) surfaces as a strong
pro-longevity prognostic marker, with a longitudinally increasing trend,
particularly in males. The trend is counter to that seen in humans
where there is a general trend downwards with age (Lai et al., 2010).
Several strains have notably high platelet numbers at 18 and 24 M;
these are WSB/EiJ, C57BL/6J and C57BL/10J. Such increased numbers
may be of advantage in cases of bleeding, possibly associated with
aggressive behaviour, or protective against cardiovascular events such
as haemorrhagic stroke. In females, the number of eosinophils (nEOS)
goes up longitudinally (Data S2 Fig. 6), associated with a long lifespan
(Data S2 Fig. 7). This effect has so far not been described in the
literature. A result that receives weaker support is the prognostic value
of T4 in females at a later age. Furthermore, the support for B cells as
pro-longevity markers is no longer as significant as before, particularly
in females. However, many results receive stronger support if the
short-lived strains are excluded. Among female mice, the affected
features are CHr, pctHCT, nRBC, Fe and Mg, and among male mice,
our observations regarding lymphocytes and neutrophils are now more
strongly supported. In the body composition data, the BMI (as well as
percentage fat) becomes prognostic for longevity of 20 M male mice,
corroborating its contribution to robustness already discussed. Finally,
the exclusion of the short-lived strains markedly increased the negative
correlation between IGF and life expectancy, confirming the observa-
tion by Yuan et al. (2009).
Comparison of longitudinal trends of short-lived and longer-
lived mice
We finally investigated whether short-lived mice display the same
longitudinal trends as longer-lived mice, and the results of our trend
comparison are found in Data S3 (Supporting information). We note few
systematic patterns as follows, in the body composition, leucocyte and
blood chemistry data. AKR/J mice show faster downtrends in terms of
body mass index (and some related measurements with negligible
longitudinal trends), possibly due to the thymic lymphoma they develop
by 18 M of age (Storer, 1966; Brayton et al., 2012). Regarding the
leucocyte data, males of the SJL/J strain are singled out by enrichment in
opposite trends. This strain is known to show aggressive behaviour in
males, leading to injury and infection and truncation of lifespan. In case
of blood chemistry, Calcium shows a faster trend in many strains, while
HDL and TP (total protein) show an opposite trend, possibly due to liver
malfunction.
Discussion
The most specific feature of any data analyses in aging research is a
focus on longitudinal data. We present here a detailed analysis of the
most extensive longitudinal mouse phenotype data set published to
date. We have integrated our findings with an extensive review of the
literature; this was an essential component in our analysis pipeline and
we present the analysis results with extensive links to observations
already published, including pointers to observations in human. In the
discussion that follows, we point out some more general aspects of our
work. First, we relate our results to an interpretation of Miller et al.
(1997), comparing feature values in young and old animals. Next, we
relate our observations to work by Harper et al. (2004), on combining
biomarkers. Finally, we discuss the perhaps most far-reaching aspect of
our analysis. Specifically, we suggest that we could demonstrate that a
critical assumption of many previous longitudinal analyses, that is, the
validity of selecting the same measurement time points for all individuals
(strains) of a study, irrespective of differences in individual longevity due
to specific early-onset diseases, may indeed be justified, by showing that
(i) data from the short-lived strains did not affect the major conclusions
of our study and (ii) the trends of the features in the short-lived strains
generally agree with the ones in the longer-lived strains.
Biomarker values in young animals compared with values in
older animals
We have described a biomarker analysis protocol that is applicable
whenever there is access to longitudinal features, corresponding life
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expectancy data and literature knowledge. Applied to the Nathan Shock
Center data set of the Mouse Phenome Database, our protocol enabled
us to detect meaningful pro-longevity, antilongevity and role-changing
biomarkers, the former with prognostic and longitudinal lines of
evidence. We have already discussed in the Introduction that these
two lines of evidence for biomarkers of aging usually relate to an
overlapping but not identical time span in the life of the animals. In case
of clear-cut longitudinally declining pro-longevity biomarkers, their early
prognostic role (high values predict a long lifespan) could in fact be
based on large amounts of effectors (cells) with a positive effect
throughout life (despite the decline), and their late longitudinal role
could be based on their gradual loss at old age. This interpretation
reflects the hypothesis of Miller et al. (1997) that young mice, whose
feature values resemble those of old mice, tend to have a short life
expectancy and vice versa. High biomarker values at young age may thus
enable mice to ‘resist’ any loss and are prognostic of longevity; if a
younger mouse features biomarker values indicating that it can
compensate the normal age-based trend of a feature when it becomes
older, this mouse has a good chance of living longer. Examples for this
hypothesis in the blood count data are the lymphocyte, B-cell and red
blood cell counts, as well as the neutrophil counts. The latter reflect
‘inflamm-aging’ as described. We note that such chronic inflammatory
processes are common to aging mice (Ray et al., 2010; Pettan-Brewer &
Treuting, 2011), consistent with similar findings in aging humans
(Krabbe et al., 2004). Elevation of neutrophil numbers in younger mice
may be due to several specific causes, see the Appendix S1 Discussion.
Biomarker combination
Biomarkers may be combined across data sets for optimal prediction of
lifespan. Corroborating our analysis, Harper et al., (2004) used (i) T-cell
features (CD4 and CD8 cells, CD4 and CD8 memory cells as well as CD4
and CD8 cells featuring P-glycoprotein, from 8- and 18-month-old mice),
(ii) body weight (from 3-month-old mice) and (iii) thyroxine and leptin
levels (from 4-month-old mice) to construct a combined classifier with
better prognostic value than classifiers based only on a subset of these
features. The most prognostic T-cell feature in young mice turned out to
be the percentage of CD8 memory cells in the pool of all CD8 cells.
Inclusion of thyroxine was based on its prognostic value in young male
mice. The biomarkers they used are thus closely related to the
biomarkers we documented. In particular, in the data based on male
mice we studied, CD8 memory central cells were found to be prognostic
of short lifespan and going up longitudinally, but without a known
deleterious effect. Insofar as the biomarkers are based on young mice
only (in case of body mass and thyroxine), we documented them as role-
switching markers, with an early antilongevity effect.
Biomarkers in short-lived vs. longer-lived animals
We included data from short-lived strains in the analyses presented. It is
possible that the specific diseases affecting these strains bias the results
of analyses aiming to find biomarkers of aging. However, our re-analysis
based on all longer-lived strains, excluding the short-lived ones, yielded
essentially the same results (Data S2); a similar procedure carried out for
the same reasons by Yuan et al. (2009) was shown to result in only
small changes in the correlation of IGF1 levels with longevity. Moreover,
we observed that the features we investigated display very similar
longitudinal trends in short-lived and longer-lived mice (Data S3). This
result provides a justification for comparing measurements according to
age groups in the first place. In the extreme case, if the features in
short-lived mice were changing ‘twice as fast’ as in longer-lived mice
due to their specific diseases, 6 M measurements of the former would
need to be compared to 12 M measurements of longer-lived mice, and
12 M measurements of the former to 24 M measurements of the latter.
More generally, measurement timelines would need to be aligned, and
this task is difficult or impossible in hindsight. However, in our
comparison of trends, such systematic patterns are rare, so features
change at a roughly similar speed in short-lived and longer-lived mice.
Thus, we suggest that along their life, mice age at a roughly similar
speed, and early death is usually due to genetic predisposition to specific
diseases. In turn, late death is influenced significantly by other effects
(that relate closely to aging) and an increasing burden of chronic disease
and co-morbidities. That is, only towards the end of life, the speed of
aging becomes markedly slower and more diverse in the longer-lived
strains.
We have confirmed and extended current knowledge in our detection
of clear-cut biomarkers. Our insights into role-switching biomarkers
consolidate previous knowledge, related to inflammation and immunity
on one hand and to anaemia and body mass on the other. Interestingly,
connecting both aspects is a focus of recent research. For example, diet-
induced obesity is known to affect the adaptive immune system
negatively (Dixit, 2012). Also, the role of trade-offs was recently
discussed in terms of robustness, citing inflammation and body size as
examples (Kriete, 2013). We believe that role-switching is an important
point to consider in biomarker analysis. Such considerations may also
have practical consequences, as biomarkers may point to possible
intervention points. Accordingly, interventions designed to promote
longevity may be useful, useless or harmful depending on the age at
intervention. While the data set we analysed is the most comprehensive
one publicly available at this time, analyses and conclusions are of course
limited by the coverage it provides, with a focus on blood. However,
with decreasing costs for high-throughput analysis of the genome,
biofluids, gut microbiome, etc., our strategy can be easily extended to
such data sets.
Experimental procedures
Data
In our analysis, we used seven longitudinal studies of the Nathan Shock
Center data set, available as of July 2013 from the Jackson Laboratory
Mouse Phenome Database (Maddatu et al., 2012) (Data S1 Table S1).
For details, we referred to the webpage of the Mouse Phenome
Database (http://phenome.jax.org). All studies used between 29 and 33
inbred mouse strains raised and taken care of under similar conditions.
Data included life expectancy, as well as blood features, bone mineral
density and body composition, DNA damage, urine values and electro-
cardiogram data.
Simple linear regression to detect longitudinal evidence
To identify the longitudinal trend of a feature over the lifespan of
individuals, we performed simple linear regression modelling using the
measured values as the dependent variable and the age as the
explanatory variable. To be able to compare the slopes between
different features, we standardized the data by subtraction of the
mean and division by the standard deviation. Regression was per-
formed using the method lm for linear models, available as part of an R
package. For each data set, the measured slopes m can be converted
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into Pearson’s correlation coefficients r by the formula r ¼ msage, where
sage denotes the standard deviation, taken over all ages, of the
distribution of the normalized values for the measurements. The
regression analyses we performed are therefore equivalent to correla-
tion analyses between the features and the age the measurement was
taken. We considered only slopes as significant for which P-values
(resulting from a two sided t-test) were smaller than 0.05 (i.e.
a = 0.05). We used regression charts to visualize the results of the
regression analyses, sorting features by slope. Originally, for the blood
count data, only the absolute number of white blood cells and the
percentages of the other cell types were given in the Mouse Phenome
Database. For completeness, we calculated the absolute cell numbers
from percentages for all cell types before performing the regression.
Sample regression analyses are visualized for the features RBC (red
blood cell count) and NEUT (neutrophil count) in Fig. S12 of Data S1
(Supporting information).
Correlation of features and life expectancy, and Cox
regression to detect prognostic evidence
No longitudinal data set included the life expectancy of the individual
mice, so we added the respective life expectancy from data set Yuan2
to each data record in all other data sets. Again, we standardized the
data by subtraction of the mean and division by the standard deviation.
Then, we calculated Pearson’s correlation coefficient as implemented in
the method cor.test, available within the R package stats, between
feature value and life expectancy. This was done separately for each
time point available (i.e. age groups 6, 12, 18, 20 and 24 M). Notably, a
positive correlation means that high feature values are prognostic for a
long lifespan, that is, longevity and vice versa. We only consider
features as relevant in terms of their prognostic evidence, if Pearson’s
correlation coefficient |r| ≥ 0.2 and P-value < 0.05 holds. In a correla-
tion chart, the correlation coefficients are plotted as histograms. Open
bars represent irrelevant values. The horizontal ordering of the features
in each correlation chart was taken directly from the regression analysis
of the same-sex mice of the same data set. Two vertical red delimiters
delineate, from left to right, features with a significant downtrend,
features with no clear trend and features with a significant uptrend.
This enables a visual impression of how the longitudinal evidence relates
to the prognostic evidence of the same feature and eases the selection
of putative biomarkers as described in the next paragraph. Univariate
and multivariate Cox regression were then done using the R package
‘survival’. In Data S4 (Supporting information), for each measured value,
we present its univariate Cox regression coefficient, which would give
rise to a hazard ratio by exponentiation. A negative Cox coefficient
results in a hazard ratio smaller than 1 (i.e. a risk decrease) and a
positive value in a risk increase. Thus, we inverted the y-axis to allow
direct comparison with the corresponding correlation chart data.
Multivariate Cox regression was applied to the biomarkers of Table 1,
exploiting data from 10 to 27 strains (depending on sex and time point)
for which no values were missing, see Data S5 (Supporting informa-
tion).
Biomarker selection and classification
We performed a detailed analysis of all relevant features that may
qualify as biomarkers of aging based on the following two criteria: (i)
the regression analysis yielded a significant slope, that is, the feature
displays a longitudinal trend; (ii) the correlation analysis also demon-
strated that the feature has prognostic evidence, at least for some age
groups. For each feature we selected, we then conducted a literature
search for what is known about its effects. Longitudinal evidence
indicates a biomarker of aging (not just of age) if there is validation by a
matching effect (i.e. a beneficial effect for features with a downtrend
and vice versa) (Gavrilov & Gavrilova, 2006). Based on regression,
correlation and literature data, biomarkers were then classified by the
rules described in Fig. 1 and Table S3 in Data S1 (Supporting
information), and the results were recorded in Table 1. The entire
classification protocol, including the final designation as a clear-cut or
role-changing biomarker, is given in Fig. 1. Specifically, biomarkers
prognostic of a long lifespan are called pro-longevity, and biomarkers
prognostic of a short lifespan are called antilongevity. Biomarkers with a
validated longitudinal uptrend are also called antilongevity, and
biomarkers with a validated longitudinal downtrend are called pro-
longevity. Biomarkers attract a clear-cut classification where there is
corroborative evidence. In particular, features whose values go down
longitudinally, with a matching beneficial effect, and predict long
lifespan or vice versa are thus clearly classified as pro-longevity or
antilongevity, respectively. In case of conflicting evidence, we classified
the features as role-switching. The classification scheme in Fig. 1 is
formulated for an ideal case. In reality, the patterns of feature
regression and correlation are more or less pronounced, due to
biological variability. We therefore added some qualifiers regarding the
resulting classification of biomarkers (Table 1). Moreover, isolated or
inconsistent prognostic evidence of the 18, 20 and 24 M age groups
was ignored, because data for these age groups are clearly the most
volatile. In particular, due to the different life expectancies of the
mouse strains (Data S1 Table S1), only one-third of all strains
contributed data to the 24 M age group. Re-analysis of data based
on longer-lived strains only and comparison of longitudinal trends of
short-lived and longer-lived mice are described in Appendix S1
Experimental Procedures.
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